Cargando…
Extracorporeal mesenchymal stromal cell therapy (SBI-101) in severe COVID-19 complicated by acute kidney injury
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society for Cell & Gene Therapy. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111903/ http://dx.doi.org/10.1016/S1465324921002772 |
_version_ | 1783690587374878720 |
---|---|
author | Teixiera, J. Atta, M.G. Noureddine, L. Nguyen, S. O’Rourke, B. Tilles, A. Bornschlegl, S. LaPointe, E. Dietz, A. Nissenson, A. Blair, A. Parekkadan, B. Barcia, R. |
author_facet | Teixiera, J. Atta, M.G. Noureddine, L. Nguyen, S. O’Rourke, B. Tilles, A. Bornschlegl, S. LaPointe, E. Dietz, A. Nissenson, A. Blair, A. Parekkadan, B. Barcia, R. |
author_sort | Teixiera, J. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8111903 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | International Society for Cell & Gene Therapy. Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81119032021-05-11 Extracorporeal mesenchymal stromal cell therapy (SBI-101) in severe COVID-19 complicated by acute kidney injury Teixiera, J. Atta, M.G. Noureddine, L. Nguyen, S. O’Rourke, B. Tilles, A. Bornschlegl, S. LaPointe, E. Dietz, A. Nissenson, A. Blair, A. Parekkadan, B. Barcia, R. Cytotherapy Article International Society for Cell & Gene Therapy. Published by Elsevier Inc. 2021-05 2021-05-11 /pmc/articles/PMC8111903/ http://dx.doi.org/10.1016/S1465324921002772 Text en Copyright © 2021 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Teixiera, J. Atta, M.G. Noureddine, L. Nguyen, S. O’Rourke, B. Tilles, A. Bornschlegl, S. LaPointe, E. Dietz, A. Nissenson, A. Blair, A. Parekkadan, B. Barcia, R. Extracorporeal mesenchymal stromal cell therapy (SBI-101) in severe COVID-19 complicated by acute kidney injury |
title | Extracorporeal mesenchymal stromal cell therapy (SBI-101) in severe COVID-19 complicated by acute kidney injury |
title_full | Extracorporeal mesenchymal stromal cell therapy (SBI-101) in severe COVID-19 complicated by acute kidney injury |
title_fullStr | Extracorporeal mesenchymal stromal cell therapy (SBI-101) in severe COVID-19 complicated by acute kidney injury |
title_full_unstemmed | Extracorporeal mesenchymal stromal cell therapy (SBI-101) in severe COVID-19 complicated by acute kidney injury |
title_short | Extracorporeal mesenchymal stromal cell therapy (SBI-101) in severe COVID-19 complicated by acute kidney injury |
title_sort | extracorporeal mesenchymal stromal cell therapy (sbi-101) in severe covid-19 complicated by acute kidney injury |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111903/ http://dx.doi.org/10.1016/S1465324921002772 |
work_keys_str_mv | AT teixieraj extracorporealmesenchymalstromalcelltherapysbi101inseverecovid19complicatedbyacutekidneyinjury AT attamg extracorporealmesenchymalstromalcelltherapysbi101inseverecovid19complicatedbyacutekidneyinjury AT noureddinel extracorporealmesenchymalstromalcelltherapysbi101inseverecovid19complicatedbyacutekidneyinjury AT nguyens extracorporealmesenchymalstromalcelltherapysbi101inseverecovid19complicatedbyacutekidneyinjury AT orourkeb extracorporealmesenchymalstromalcelltherapysbi101inseverecovid19complicatedbyacutekidneyinjury AT tillesa extracorporealmesenchymalstromalcelltherapysbi101inseverecovid19complicatedbyacutekidneyinjury AT bornschlegls extracorporealmesenchymalstromalcelltherapysbi101inseverecovid19complicatedbyacutekidneyinjury AT lapointee extracorporealmesenchymalstromalcelltherapysbi101inseverecovid19complicatedbyacutekidneyinjury AT dietza extracorporealmesenchymalstromalcelltherapysbi101inseverecovid19complicatedbyacutekidneyinjury AT nissensona extracorporealmesenchymalstromalcelltherapysbi101inseverecovid19complicatedbyacutekidneyinjury AT blaira extracorporealmesenchymalstromalcelltherapysbi101inseverecovid19complicatedbyacutekidneyinjury AT parekkadanb extracorporealmesenchymalstromalcelltherapysbi101inseverecovid19complicatedbyacutekidneyinjury AT barciar extracorporealmesenchymalstromalcelltherapysbi101inseverecovid19complicatedbyacutekidneyinjury |